Company / R&D Expense
Kraig Biocraft Laboratories, Inc. R&D Expense History
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$223.1K
FY2019
5-year range
$148.1K / $432.0K
FY2015-FY2019
Trend
+50.6%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense returned to growth in FY2019 after 5 years of decline, reaching $223,050.
Based on SEC 10-K filings.
$223,050 in FY2019 with a 5-year CAGR of -12.7%.
Declined from $258,892 to $223,050 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -17.5%
- 5-Year CAGR
- -12.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -12.7%, indicating a declining trend.
- In FY2019, r&d expense increased 50.6% year-over-year.
- Peak r&d expense was recorded in FY2013.
- Lowest r&d expense in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -50.01 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $223.1K | +50.6% |
| FY2018 | $148.1K | -42.8% |
| FY2017 | $258.9K | -34.8% |
| FY2016 | $397.1K | -8.1% |
| FY2015 | $432.0K | -1.7% |
| FY2014 | $439.5K | -10.2% |
| FY2013 | $489.4K | +5.2% |
| FY2012 | $465.3K | - |
As of FY2019 · SEC 10-K · Updated Jun 29, 2026